Inspection of Product. (a) RPRPI will, or will cause the Designated Manufacturer to, conduct quality control testing and formal release of Product in accordance with the RPRPI standard quality control procedures that are part of the Product Specifications ("RPRPI-Standard QA"), and to provide Watsxx xxxh a certificate of analysis for all batches of Product shipped to Watsxx. Xxlivery of any Product by RPRPI to Watsxx xxxll constitute a certification by RPRPI that the Product conforms to the Product Specifications, except in the case of quarantined shipments, described below. RPRPI may ship Product to Watsxx xxxectly from the Designated Manufacturer's facility, and Watsxx xxxees to accept delivery for Product, in quarantine. Watsxx xxxll store all Product in controlled conditions as specified in the Specifications. In the event a shipment is delivered in quarantine, Watsxx xxxl extract and deliver to RPRPI or the Designated Manufacturer samples of the quarantined shipment pursuant to RPRPI-Standard QA, for quality control testing by RPRPI. Upon satisfactory completion of such RPRPI-Standard QA, RPRPI will, or will cause the Designated Manufacturer to, release such shipment by delivering to Watsxx x xritten notice releasing such shipment, accompanied by a certificate of analysis pertaining to such shipment. In the case of quarantined shipments, such release by RPRPI will constitute a certification by RPRPI that the Product conforms to the Product Specifications. RPRPI will have the right at reasonable times and on reasonable notice to inspect Watsxx'x xxxtribution center for compliance with the aforementioned conditions for storage and treatment of quarantined shipments, but such right may not be exercised more than once in any period of twelve consecutive months unless RPRPI has a good faith reason to believe the Product is not being handled and stored in accordance with the Product Specifications and/or such facility is not in compliance in any material respect with FDA Standards or other applicable law. Such inspection shall be conducted at RPRPI's sole cost and expense in a manner so as reasonably to minimize disruption of Watsxx'x xxxiness operations, provided that Watsxx xxxll reimburse RPRPI for such costs if such inspection reveals a material non-compliance with Product Specifications, FDA Standards or any applicable law.
Inspection of Product. 8.1 Upon receipt of each Delivery of Products, Customer shall promptly perform an inspection of the package, the packing list, labeling and the Products in accordance with sound business practice.
Inspection of Product. Medtronic shall inspect all Products promptly upon receipt thereof, and in the event of any shortage, damage or discrepancy in or to a shipment of Products or in the event any of the Products fail to comply with the then current Specifications for the Products (except for latent defects not readily observable by Medtronic), Medtronic shall report the same to MacroPore within 60 days after delivery thereof to Medtronic and furnish such written evidence or other documentation as MacroPore reasonably may deem appropriate. If the substantiating evidence delivered by Medtronic reasonably demonstrates that such shortage, damage or discrepancy or nonconformity with Specifications existed at the time of delivery of the Products, Medtronic may return the Products to MacroPore, at MacroPore's expense, and, at Medtronic's request, MacroPore shall use all reasonable efforts to deliver promptly replacement Products to Medtronic in accordance with the delivery procedures set forth herein. Any Products not rejected by Medtronic by written notice given to MacroPore within such 60-day period (other than Products containing latent defects not readily observable by Medtronic) shall be deemed to have been accepted by Medtronic. Following any such acceptance, the sole remedies of Medtronic with respect to damage to or defects in the Products shall be those set forth in Sections 9.2 and 11.1.
Inspection of Product. All product(s) ordered shall be subject to inspection and acceptance by the LCBO. Such acceptance will be given within a reasonable time after receipt of the products at the LCBO's warehouse, if the products are in satisfactory condition as described herein.
Inspection of Product. Within sixty (60) calendar days of the arrival of each lot of Product at the U.S. location designated by Lannett, Lannett shall inspect and test each lot of Product at its own cost and expense. If, upon inspecting and testing the Product, Lannett determines that a Product lot does not materially conform to the Product Specifications or to any of the warranties contained in Section 4.1 (any quantity of such Product, the “Non-Conforming Product”), then Lannett shall, within such sixty (60) day period, in the case of any defects readily observable based on visual inspection of the packaged Product or the accompanying certificates, give Seller written notice of such Non-Conforming Product (setting forth the details of such non-conformity).
Inspection of Product. Arch shall test and inspect all Product before shipment thereof for compliance with the Specification. Upon receipt of each shipment of Product, Codexis, or a Third Party designated by Codexis, shall test and inspect such Product for compliance with the Specification and Purchase Orders. Acceptance by Codexis of all or part of each shipment of Product delivered by Arch shall be subject to compliance of Product with the Specification as determined by such acceptance inspection. Codexis shall inform Arch of the result of the acceptance inspection including the judgment of acceptance or rejection of all or part of a shipment in writing within [*] after the receipt of such shipment of Product. If Codexis fails to notify Arch of a rejection within such [*] period, the shipment of Product shall be deemed accepted by Codexis. [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Inspection of Product. Eden or its representative will inspect all Compositions promptly upon receipt, and in the event of any shortage, damage or discrepancy or in the event any of the Compositions fail to comply with the then Specifications (except for defects not readily observable by Eden without opening the packaging thereof), Eden will report the same to PHC within fifteen (15) days after receipt, in which event Eden will furnish written evidence or other documentation, as appropriate. If the substantiating evidence delivered by Eden reasonably demonstrates that such shortage, damage, discrepancy or nonconformity with Specifications existed at the time of delivery, Eden may return the Compositions to PHC at PHC’s expense and, at Eden’s request and option, PHC will either promptly replace the Compositions in accordance with the delivery procedures set forth herein or refund or credit Eden’s account for the full invoice value, together with any commercially reasonable shipping, inspection and return costs incurred by Eden. Any Compositions not rejected by Eden by written notice to PHC within fifteen (15) days after delivery (other than Compositions containing latent defects not readily observable by Eden) will be deemed to have been accepted by Eden. Following acceptance, the sole remedies of Eden with respect to nonconformities, damage or defects in the Compositions will be those set forth in Section 7.
Inspection of Product. US Bio shall examine the Product upon delivery at US Bio’s designated facility and shall notify Dyax in writing (including via email or other electronic communication) within one (1) business day of any problems relating to the quantity of Product delivered or any defect in any of the Product that is reasonably discoverable upon visual inspection of the Product without unpacking of pallets.
Inspection of Product. Upon receipt of each shipment of Product, Codexis and/or the Codexis Customer, shall test and inspect such Product for compliance with the Product Specification and other documentation as set forth in Section 3.12 or otherwise provided by Codexis to Arch pursuant to Section 3.7 (as applicable) for such Product corresponding to [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. such shipment. Codexis and/or the Codexis Customer shall inform Arch of the result of the acceptance inspection including the judgment of acceptance or rejection of all or part of a shipment in writing within ten (10) days (or such other time as may be agreed to by Codexis and a Codexis Customer, as specified in the applicable Product Purchase Order) after the delivery of such shipment of Products. In the event that Arch receives a written notice of rejection from Codexis and/or the Codexis Customer within the timeframes set forth in the following sentence, subject to Section 3.11, Arch shall replace such rejected Product pursuant to Section 3.10. If Codexis and/or the Codexis Customer fails to notify Arch of a rejection within the requisite timeframe, the shipment of Products shall be deemed accepted by Codexis and/or the Codexis Customer. Regardless of any rejection of all or part of a shipment of Product, Codexis shall pay for such Product and if such rejection is determined to be proper by Arch or pursuant to the dispute resolution mechanism set forth in Section 3.11, Codexis shall be entitled to, at its sole discretion, a credit or refund of such properly rejected Product.
Inspection of Product. Acceptance or Rejection
